ImmPACT Bio Names Sylvain Roy as Chief Technology Officer

— Longtime pharmaceutical industry executive brings over two decades of experience in cell and gene therapy, global technical operations, and leading high-performing teams — CAMARILLO, Calif., May 10, 2022 /PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company...

Click to view original post